전임상 바이오 분석 시험 서비스 시장 : 워크플로우별, 분자별, 시험별, 최종 용도별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Preclinical Bioanalytical Testing Services Market size was valued at US$ 1,234.56 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Preclinical Bioanalytical Testing Services Market is a contract research and laboratory services segment that supports drug development by analyzing drug candidates' pharmacokinetics (PK), toxicology, biomarkers, and bioavailability prior to clinical trials. These services provide a reliable, compliant, and data-driven assessment of a molecule's safety and efficacy. The increasing number of biologics and complex modalities that require advanced analytical platforms is driving market growth. An important trend is the growing use of high-sensitivity LC-MS/MS and automation to improve throughput and data accuracy. However, the market faces constraints such as high operational costs and stringent regulatory expectations, which lengthen testing timelines. Despite these challenges, the expansion of outsourcing by pharmaceutical and biotechnology companies, particularly for specialty assays and method development, represents a significant opportunity, making preclinical bioanalytical services an essential component of modern drug discovery pipelines.

Preclinical Bioanalytical Testing Services Market- Market Dynamics

Increasing Prevalence of Chronic Diseases Propel Growth In The Market

The rising prevalence of chronic diseases is expected to drive future growth in the preclinical bioanalytical testing services market. Chronic disease is a type of illness that lasts three months or longer and can deteriorate over time. Bioanalytical testing services assist in identifying and measuring specific biomarkers associated with chronic diseases, as well as therapeutic drug monitoring, ensuring that drug levels in the patient's body remain within the therapeutic range. For instance, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition will rise by 99.5%, or 142.66 million, by 2050. Furthermore, the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, reported 41 million deaths in September 2022, accounting for 74% of all deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide. As a result, the rising prevalence of chronic diseases fuels the expansion of the Preclinical bioanalytical testing services industry.

Preclinical Bioanalytical Testing Services Market- Segmentation Analysis:

The Global Preclinical Bioanalytical Testing Services Market is segmented by Workflow, Molecule, Test, End Use and Region.

According to the test, the bioavailability test segment will be the most important in the market for bioanalytical testing services. Bioavailability is critical in determining the efficacy of a new drug's pharmacokinetic profile after administration in clinical trials. Furthermore, there has been an increase in the number of active clinical trials. As a result, incorporating bioavailability testing into these trials is critical to ensuring consistency and stability among formulations used, ultimately improving patient outcomes. For instance, according to a report published in February 2023 by the WHO International Clinical Trials Registry Platform (ICTRP), clinical trial registrations in the Western Pacific region increased significantly in 2022. This increase is primarily due to the large number of clinical trial registrations in China and Japan, which rank first and second in the region, respectively.

By Workflow, the Sample Collection and Preparation segment takes over the market due to its selectivity, convenience, speed, and extraction phase configurations. Technology-driven sample preparations are being developed to meet the growing demand for automation, reduced solvent usage, and miniaturization, resulting in on-site, in situ, and in vivo applications. For example, in November 2023, Thermo Fisher Scientific introduced automated sample preparation solutions for laboratories certified for in vitro diagnostics (IVD) and in vitro diagnostic regulation (IVD-R). The new solutions will help to improve and automate respiratory diagnostic testing.

Preclinical Bioanalytical Testing Services Market- Geographical Insights

North America stands out in the preclinical bioanalytical testing services market due to its innovative spirit and robust infrastructure. The region boasts well-established and developed facilities. The United States, in particular, has a high demand for bioanalytical testing services due to its large pharmaceutical and biotechnology industries. Furthermore, strict FDA regulations in the region ensure that pharmaceutical companies maintain high-quality testing standards, necessitating bioanalytical testing services. As a result, major companies are expanding their testing service portfolios to meet rising demand. In August 2024, SGS Societe Generale de Surveillance SA launched its new bioanalytical testing services in North America with the help of Agilex Biolabs Pty Ltd. This expansion expands testing solutions and boosts market growth by offering comprehensive support for clinical trials and drug development.

United States Preclinical Bioanalytical Testing Services Market- Country Insights

The US market is rapidly expanding, owing to increased demand for precision medicine and an expanding pipeline of biologics and biosimilars. According to industry reports, the United States had 64 approved biosimilars as of December 2024, demonstrating the country's leadership in biologics innovation and the resulting demand for bioanalytical validation. The growing importance of pharmacokinetic and pharmacodynamic studies in drug development has increased the demand for specialized analytical methods. Furthermore, increased funding for life sciences research and a strong emphasis on regulatory compliance have prompted the outsourcing of bioanalytical testing to ensure consistent data quality. The application of cutting-edge technologies in analytical workflows, such as high-throughput screening and LC-MS/MS, improves result accuracy and turnaround time.

Preclinical Bioanalytical Testing Services Market- Competitive Landscape:

The preclinical bioanalytical testing services market has a competitive landscape that includes a large number of players, ranging from established companies to emerging startups. The market is highly fragmented, with key players prioritizing strategic collaborations, mergers and acquisitions, and technological advancements to strengthen their market positions. The growing demand for specialized bioanalytical services, fueled by advances in pharmaceutical and biotechnology research, has increased competition, prompting businesses to broaden their service offerings and geographic reach. The emphasis on quality, dependability, and regulatory compliance remains a critical differentiator in this competitive environment. Major companies in the bioanalytical testing services market include Thermo Fisher Scientific Inc (PPD, Inc.), Parexel International, Pharmaron, and BioAgilytix Labs. These companies have established themselves as industry leaders, providing a wide range of bioanalytical services to pharmaceutical and biotechnology companies.

Recent Developments:

In June 2024, Lebanon, a New Jersey laboratory facility in Curia, was acquired by Pace Analytical Services. The acquisition will offer support to drug development partners that are new in the market by providing rapid and highly expert development and analytical laboratory services on a commercial basis across the biopharma sector.

In November of 2024, Altasciences stated that it has expanded its bioanalytical service portfolio by providing flexible, high-quality analytical solutions for preclinical and clinical studies, reinforcing its 30-year commitment to accelerating global drug development and client success.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Charles River Laboratories International
• Syneos Health
• SGS SA
• WuXi AppTec
• Thermo Fisher Scientific Inc (PPD, Inc.)
• Parexel International
• Pharmaron
• BioAgilytix Labs
• KCAS Bio
• ICON plc
• Labcorp
• Eurofins Scientific SE
• QPS Holdings
• Altasciences
• Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY WORKFLOW- MARKET ANALYSIS, 2019 - 2032

• Sample Analysis
• Hyphenated technique
• Chromatographic technique
• Electrophoresis
• Ligand Binding Assay
• Mass Spectrometry
• Spectroscopic Techniques
• Genomic and Molecular Techniques
• Method Development and Validation
• Sample Collection and Preparation
• Sample Collection, Handling and Storage
• Protein Precipitation
• Liquid-Liquid Extraction
• Solid Phase Extraction
• Others
• Other processes

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032

• Small Molecule
• Large Molecule

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY TEST- MARKET ANALYSIS, 2019 - 2032

• Bioavailability
• Bioequivalence
• Biomarker Testing
• ADME
• In-vivo
• In-vitro
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Cell-based Assay
• Virology Testing
• Other Tests

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

• CDMO
• CRO
• Pharma & BioPharma Companies
• Others

GLOBAL PRECLINICAL BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Preclinical Bioanalytical Testing Services Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Preclinical Bioanalytical Testing Services Market Snippet by Workflow
  • 2.1.2. Preclinical Bioanalytical Testing Services Market Snippet by Molecule
  • 2.1.3. Preclinical Bioanalytical Testing Services Market Snippet by Test
  • 2.1.4. Preclinical Bioanalytical Testing Services Market Snippet by End Use
  • 2.1.5. Preclinical Bioanalytical Testing Services Market Snippet by Country
  • 2.1.6. Preclinical Bioanalytical Testing Services Market Snippet by Region
• 2.2. Competitive Insights

3. Preclinical Bioanalytical Testing Services Key Market Trends

• 3.1. Preclinical Bioanalytical Testing Services Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Preclinical Bioanalytical Testing Services Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Preclinical Bioanalytical Testing Services Market Opportunities
• 3.4. Preclinical Bioanalytical Testing Services Market Future Trends

4. Preclinical Bioanalytical Testing Services Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Preclinical Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Preclinical Bioanalytical Testing Services Market Landscape

• 6.1. Preclinical Bioanalytical Testing Services Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Preclinical Bioanalytical Testing Services Market - By Workflow

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Workflow, 2024 & 2032 (%)
  • 7.1.2. Sample Analysis
    • 7.1.2.1. Hyphenated technique
    • 7.1.2.2. Chromatographic technique
    • 7.1.2.3. Electrophoresis
    • 7.1.2.4. Ligand Binding Assay
    • 7.1.2.5. Mass Spectrometry
    • 7.1.2.6. Spectroscopic Techniques
    • 7.1.2.7. Genomic and Molecular Techniques
  • 7.1.3. Method Development and Validation
  • 7.1.4. Sample Collection and Preparation
    • 7.1.4.1. Sample Collection, Handling and Storage
    • 7.1.4.2. Protein Precipitation
    • 7.1.4.3. Liquid-Liquid Extraction
    • 7.1.4.4. Solid Phase Extraction
    • 7.1.4.5. Others
  • 7.1.5. Other processes

8. Preclinical Bioanalytical Testing Services Market - By Molecule

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
  • 8.1.2. Small Molecule
  • 8.1.3. Large Molecule

9. Preclinical Bioanalytical Testing Services Market - By Test

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
  • 9.1.2. Bioavailability
  • 9.1.3. Bioequivalence
  • 9.1.4. Biomarker Testing
  • 9.1.5. ADME
    • 9.1.5.1. In-vivo
    • 9.1.5.2. In-vitro
  • 9.1.6. Pharmacokinetics (PK)
  • 9.1.7. Pharmacodynamics (PD)
  • 9.1.8. Cell-based Assay
  • 9.1.9. Virology Testing
  • 9.1.10. Other Tests

10. Preclinical Bioanalytical Testing Services Market - By End Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Molecule, 2024 & 2032 (%)
  • 10.1.2. CDMO
  • 10.1.3. CRO
  • 10.1.4. Pharma & BioPharma Companies
  • 10.1.5. Others

11. Preclinical Bioanalytical Testing Services Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Preclinical Bioanalytical Testing Services Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Preclinical Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Bioanalytical Testing Services Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Charles River Laboratories International
  • 12.2.2. Syneos Health
  • 12.2.3. SGS SA
  • 12.2.4. WuXi AppTec
  • 12.2.5. Thermo Fisher Scientific Inc (PPD, Inc.)
  • 12.2.6. Parexel International
  • 12.2.7. Pharmaron
  • 12.2.8. BioAgilytix Labs
  • 12.2.9. KCAS Bio
  • 12.2.10. ICON plc
  • 12.2.11. Labcorp
  • 12.2.12. Eurofins Scientific SE
  • 12.2.13. QPS Holdings
  • 12.2.14. Altasciences
  • 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us